Jie Wang

Jie Wang

Auto-generated profile, based on publicly available information

Jie Wang

Minhang Hospital, Fudan University, and Shanghai Key Laboratory of Medical Epigenetics, International Co-laboratory of Medical Epigenetics and Metabolism (Ministry of Science and Technology), Institutes of Biomedical of Sciences, Fudan University, Shanghai, China

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2021 in OncoTargets and Therapy
Verified
Journal Article
Open access
PDF file
JWJie Wang
Jie Wang
YJYing-Hua Jiang
Ying-Hua Jiang
PYPeng-Yuan Yang
Peng-Yuan Yang
FLFeng Liu
Feng Liu
Purpose: Colorectal cancer (CRC) is the third most common cancer in males and the second in females worldwide with very poor prognosis. Extracellular matrix proteins like collagens play important roles in cancer progression. Collagen type V α 2 (COL5A2) is increased in several cancers but its role in cancer remains unclear. Methods: COL5A2 expression was evaluated by interrogation of public Oncomine gene microarray datasets and immunohistochemistry (IHC) analyses of two tissue microarrays containing 180 paired CRC cases. Survival analysis was performed using Kaplan–Meier survival curve and Cox proportional hazards regression methods. COL5A2 was ectopically expressed in CRC cells, and the cell proliferation was measured using the methylthiazolyldiphenyl-tetrazolium bromide (MTT) method. Results: COL5A2 gene was significantly upregulated in the most types of CRC comparing with the normal counterparts. The mRNA expression of COL5A2 was associated with cancer stages, gender, recurrence, microsatellite instability and KRAS status of CRC. COL5A2 protein increased in the cancer epithelial cells comparing with the normal counterpart and associated with age and T stage of CRC, whereas stromal expression of COL5A2 has no significant change between cancerous and normal tissues. COL5A2 gene and protein (epithelial expression) are independent risk factors and predict poor prognosis of CRC. Ectopic expression of COL5A2 drives colon cancer cell growth and upregulates WNT/β-catenin and PI3K/mTOR signaling via binding DDR1. Conclusion: COL5A2 is a potential prognostic marker of CRC.

21 July 2021 in Oncogene
Verified
Journal Article
Closed access
PDF file
JWJie Wang
Jie Wang
HYHai-Bo Yan
Hai-Bo Yan
QZQian Zhang
Qian Zhang
WLWei-Yan Liu
Wei-Yan Liu
YJYing-Hua Jiang
Ying-Hua Jiang
FLFeng Liu
Feng Liu

21 July 2026 in JHEP Reports
Verified
Journal Article
Open access
RGRuijie Gong
Ruijie Gong
LWLinchen Wang
Linchen Wang
DXDongdong Xue
Dongdong Xue
JCJiabin Cai
Jiabin Cai
YJYurou Jiang
Yurou Jiang
DSDanjun Song
Danjun Song